39 pages. Presented to the Department of General Science and the Robert D. Clark Honors College in partial fulfillment of the requirements for the degree of Bachelor of Science June 2018Previous research has shown that autoimmune disorders like inflammatory bowel disease (IBD) are on the rise in wealthy nations such as the United States. However, virtually no research on IBD or its precursors, has been conducted in less wealthy nations. The present study addresses this issue by looking at demographic trends in levels of fecal calprotectin (FC), a biomarker of intestinal inflammation closely related to IBD, in a sample (n=79; 37 males, 42 females) of Shuar forager-horticulturalists from Ecuadorian Amazonia. There was a significant negative r...
Inflammatory bowel disease (IBD) has become a 'prototype disease' for chronic auto-inflammatory diso...
Introduction: Inflammatory bowel disease is among themost common diseases increasing rapidly in some...
Inflammatory bowel disease (IBD) is a chronic relapsing immune-mediated disease of the intestinal tr...
Background: Inflammatory bowel disease (IBD) is a chronic disease with a relapsing course of inflamm...
Inflammatory bowel disease (IBD) has long been considered a disease that affects predominantly a Wes...
Peer reviewed: TrueAcknowledgements: The authors are indebted to Dr. Justo Lorenzo-Bermejo and colla...
© 2013 Dr. Lani PrideauxThe incidence of inflammatory bowel disease (IBD) in Australia is equal to t...
Inflammatory bowel disease (IBD) is increasing in many countries 'beyond the West'. This increase ma...
8 páginasThe incidence of inflammatory bowel disease (IBD) is on the rise in Latin America. The aims...
Background. The number of patients of all age brackets diagnosed with Inflammatory Bowel Disease (IB...
© 2015 Dr. Guruparan IyngkaranThe aetiology of inflammatory bowel disease (IBD) is yet unknown but i...
Context The term inflammatory bowel disease (IBD) classically includes ulcerative colitis ...
Fecal Calprotectin is released in colon by activated neutrophils. Investigation of diagnostic a...
Background: Inflammatory bowel disease diagnosis was still based on invasive examination, such as en...
Inflammatory bowel disease (IBD) is an immunological disorder, encompassing Crohn’s disease and ulce...
Inflammatory bowel disease (IBD) has become a 'prototype disease' for chronic auto-inflammatory diso...
Introduction: Inflammatory bowel disease is among themost common diseases increasing rapidly in some...
Inflammatory bowel disease (IBD) is a chronic relapsing immune-mediated disease of the intestinal tr...
Background: Inflammatory bowel disease (IBD) is a chronic disease with a relapsing course of inflamm...
Inflammatory bowel disease (IBD) has long been considered a disease that affects predominantly a Wes...
Peer reviewed: TrueAcknowledgements: The authors are indebted to Dr. Justo Lorenzo-Bermejo and colla...
© 2013 Dr. Lani PrideauxThe incidence of inflammatory bowel disease (IBD) in Australia is equal to t...
Inflammatory bowel disease (IBD) is increasing in many countries 'beyond the West'. This increase ma...
8 páginasThe incidence of inflammatory bowel disease (IBD) is on the rise in Latin America. The aims...
Background. The number of patients of all age brackets diagnosed with Inflammatory Bowel Disease (IB...
© 2015 Dr. Guruparan IyngkaranThe aetiology of inflammatory bowel disease (IBD) is yet unknown but i...
Context The term inflammatory bowel disease (IBD) classically includes ulcerative colitis ...
Fecal Calprotectin is released in colon by activated neutrophils. Investigation of diagnostic a...
Background: Inflammatory bowel disease diagnosis was still based on invasive examination, such as en...
Inflammatory bowel disease (IBD) is an immunological disorder, encompassing Crohn’s disease and ulce...
Inflammatory bowel disease (IBD) has become a 'prototype disease' for chronic auto-inflammatory diso...
Introduction: Inflammatory bowel disease is among themost common diseases increasing rapidly in some...
Inflammatory bowel disease (IBD) is a chronic relapsing immune-mediated disease of the intestinal tr...